The authors characterized a truncation mutation, W333*, as a loss-of-function mutation, and it was proposed that MLK1 acts as a tumour suppressor in melanoma; however, this mutation was not confirmed in the primary tumour sample8. The gene discussed is MAP3K9; the disease is melanoma.